If you're using or thinking about trying compounded Tirzepatide for weight management or diabetes, pay close attention—big changes are coming. The FDA has officially removed Tirzepatide from its drug shortage list, meaning compounded Tirzepatide will no longer be available after March 19, 2025.
❓ What Does This Mean for You?
For the past year, compounding pharmacies have been able to create Tirzepatide due to a nationwide shortage of the brand-name versions, Mounjaro and Zepbound. But now that the FDA considers the shortage resolved, this option is coming to an end.
After March 19, 2025, you won’t be able to get compounded Tirzepatide from a compounding pharmacy anymore.
If this medication is part of your health journey, you must act quickly to secure your supply before it's too late.
✅ What Can You Do Right Now?
To ensure you don’t experience any disruptions in your treatment, here’s what you need to do:
🕒 Secure Up to a 5-Month Supply Before March 19
Compounded Tirzepatide is still available, but only for a limited time. If you act fast, you may be able to get a supply that lasts up to five months—but this is first-come, first-served. Once it’s gone, it’s gone!
💬 Talk to Your Doctor or Pharmacist ASAP
If you rely on Tirzepatide for weight loss or diabetes management, now is the time to explore alternatives. Mounjaro and Zepbound are FDA-approved options you may want to discuss with your healthcare provider.
Contact Us for Help
If you have any questions or need assistance securing your supply, reach out to one of our locations today.
Longmont
Phone: 303-776-0709
Text: 720-753-4362
Fort Collins
Phone: 970-225-1234
Text: 970-236-7595
Greeley
Phone: 970-576-3178
Text: 970- 236-7583
Johnstown
Phone: 970-587-1128
Text: 970-236-7726
We’re here to guide you through this transition and ensure you continue receiving the care you need.
Don’t Wait – Act Now
The deadline to get compounded Tirzepatide is coming fast. Call us or visit us today to discuss your options!
Comments